• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性自身免疫性风湿疾病所致间质性肺疾病患者的性别、年龄、生理模型及其他预后因素的验证

Validation of the gender, age, physiology model and other prognostic factors in interstitial lung disease patients with systemic autoimmune rheumatic disease.

作者信息

Hwang Yun Jung, Lee Ju Kwang, Lee Jang Ho, Ahn Yura, Lee Sang Min, Hong Seokchan, Kim Ho Cheol

机构信息

Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea.

Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mokdong Hospital, College of Medicine, Ewha Womans University, Seoul, South Korea.

出版信息

Sci Rep. 2025 Jul 9;15(1):24691. doi: 10.1038/s41598-025-08484-3.

DOI:10.1038/s41598-025-08484-3
PMID:40634418
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12241621/
Abstract

Patients with systemic autoimmune rheumatic diseases-interstitial lung disease (SARD-ILD) exhibit diverse clinical courses, highlighting the importance of prognostic prediction for effective management. This study aimed to validate the gender-age-physiology (GAP) model in patients with SARD-ILD and identify additional prognostic factors. Clinical data of patients diagnosed with SARD-ILD at a tertiary center in South Korea were retrospectively analyzed. Using variables from the GAP model, along with exercise capacity, chest computed tomography (CT) patterns, and clinical course factors such as progressive pulmonary fibrosis (PPF), multivariate and survival analyses were performed to evaluate prognostic factors for 3-year mortality. Among 142 patients with SARD-ILD, 27 died and one underwent lung transplantation over a median follow-up period of 32.8 months. In the multivariate analysis, higher GAP stages, the combination of radiologic usual interstitial pneumonia (UIP) patterns and exertional hypoxia during the 6-min walk test (hazard ratio [HR]: 2.506, P = 0.049), and PPF (HR 3.481, P = 0.001) were independently associated with 3-year mortality. Additionally, among patients in advanced GAP groups (GAP stage II or III, n = 45), those with both exertional hypoxia and a UIP pattern had significantly worse prognosis (median survival: 18.0 vs. 31.2 months, P = 0.042). Additional prognostic factors beyond the GAP model were identified, including exercise capacity, CT imaging patterns, and clinical course. These findings underscore the importance of incorporating multiple prognostic indicators for improved stratification and management of patients with SARD-ILD.

摘要

系统性自身免疫性风湿疾病-间质性肺疾病(SARD-ILD)患者表现出多样的临床病程,这凸显了预后预测对有效管理的重要性。本研究旨在验证SARD-ILD患者的性别-年龄-生理学(GAP)模型,并确定其他预后因素。对韩国一家三级中心诊断为SARD-ILD的患者的临床数据进行了回顾性分析。使用GAP模型中的变量,以及运动能力、胸部计算机断层扫描(CT)模式和进行性肺纤维化(PPF)等临床病程因素,进行多变量和生存分析以评估3年死亡率的预后因素。在142例SARD-ILD患者中,中位随访期为32.8个月,27例死亡,1例接受了肺移植。在多变量分析中,较高的GAP分期、放射学普通型间质性肺炎(UIP)模式与6分钟步行试验期间运动性低氧血症的组合(风险比[HR]:2.506,P = 0.049)以及PPF(HR 3.481,P = 0.001)与3年死亡率独立相关。此外,在晚期GAP组(GAP分期II或III,n = 45)的患者中,同时具有运动性低氧血症和UIP模式的患者预后明显更差(中位生存期:18.0对31.2个月,P = 0.042)。确定了GAP模型之外的其他预后因素,包括运动能力、CT成像模式和临床病程。这些发现强调了纳入多个预后指标以改善SARD-ILD患者分层和管理的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05a/12241621/7c7bb1994dbf/41598_2025_8484_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05a/12241621/86067418dac2/41598_2025_8484_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05a/12241621/5620f0dc887a/41598_2025_8484_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05a/12241621/f279ed838006/41598_2025_8484_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05a/12241621/7c7bb1994dbf/41598_2025_8484_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05a/12241621/86067418dac2/41598_2025_8484_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05a/12241621/5620f0dc887a/41598_2025_8484_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05a/12241621/f279ed838006/41598_2025_8484_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b05a/12241621/7c7bb1994dbf/41598_2025_8484_Fig4_HTML.jpg

相似文献

1
Validation of the gender, age, physiology model and other prognostic factors in interstitial lung disease patients with systemic autoimmune rheumatic disease.系统性自身免疫性风湿疾病所致间质性肺疾病患者的性别、年龄、生理模型及其他预后因素的验证
Sci Rep. 2025 Jul 9;15(1):24691. doi: 10.1038/s41598-025-08484-3.
2
Clinical, radiologic, and serologic predictors of rheumatic disease in interstitial lung disease patients.间质性肺疾病患者风湿性疾病的临床、影像学和血清学预测指标
Clin Rheumatol. 2025 Jun 11. doi: 10.1007/s10067-025-07505-w.
3
Dynamics of interstitial lung disease following immunosuppressive treatment differ between antisynthetase syndrome and systemic sclerosis.免疫抑制治疗后间质性肺疾病的动态变化在抗合成酶综合征和系统性硬化症之间存在差异。
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251336896. doi: 10.1177/17534666251336896. Epub 2025 May 8.
4
[F]FDG PET/CT Predicts Patient Survival in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease.[F]氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描可预测系统性硬化症相关间质性肺疾病患者的生存率。
J Nucl Med. 2025 Jul 1;66(7):1135-1141. doi: 10.2967/jnumed.125.269497.
5
Predicting the risk of subsequent progression in patients with systemic sclerosis-associated interstitial lung disease with progression: a multicentre observational cohort study.预测系统性硬化症相关间质性肺病进展患者后续病情进展的风险:一项多中心观察性队列研究。
Lancet Rheumatol. 2025 Jul;7(7):e463-e471. doi: 10.1016/S2665-9913(25)00026-8. Epub 2025 May 14.
6
Detection of decline in pulmonary function in patients with systemic sclerosis-associated interstitial lung disease using home monitoring in the Netherlands (DecreaSSc): a prospective, observational study.在荷兰使用家庭监测检测系统性硬化症相关间质性肺病患者的肺功能下降(DecreaSSc):一项前瞻性观察研究。
Lancet Rheumatol. 2025 Mar;7(3):e178-e186. doi: 10.1016/S2665-9913(24)00236-4. Epub 2024 Nov 8.
7
Diagnostic and prognostic trajectories of interstitial lung diseases after the multidisciplinary discussion.多学科讨论后间质性肺疾病的诊断和预后轨迹
Ther Adv Respir Dis. 2025 Jan-Dec;19:17534666251323487. doi: 10.1177/17534666251323487. Epub 2025 Mar 13.
8
Cyclophosphamide for connective tissue disease-associated interstitial lung disease.环磷酰胺用于治疗结缔组织病相关的间质性肺疾病。
Cochrane Database Syst Rev. 2018 Jan 3;1(1):CD010908. doi: 10.1002/14651858.CD010908.pub2.
9
Computed tomography-based quantitative scoring system for rheumatoid arthritis-associated interstitial lung disease: a retrospective diagnostic accuracy study for progressive fibrosis detection.基于计算机断层扫描的类风湿关节炎相关间质性肺疾病定量评分系统:一项用于检测进行性纤维化的回顾性诊断准确性研究
Clin Rheumatol. 2025 Jul;44(7):2669-2681. doi: 10.1007/s10067-025-07511-y. Epub 2025 Jun 9.
10
Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene.慢性阻塞性肺疾病基因研究中疑似间质性肺疾病的发展、进展及死亡率
Am J Respir Crit Care Med. 2024 Dec 15;210(12):1453-1460. doi: 10.1164/rccm.202402-0313OC.

本文引用的文献

1
External validation and longitudinal application of the DO-GAP index to individualise survival prediction in idiopathic pulmonary fibrosis.DO-GAP指数在特发性肺纤维化个体生存预测中的外部验证及纵向应用
ERJ Open Res. 2023 May 9;9(3). doi: 10.1183/23120541.00124-2023. eCollection 2023 May.
2
Prevalence, imaging patterns and risk factors of interstitial lung disease in connective tissue disease: a systematic review and meta-analysis.结缔组织病相关性间质性肺疾病的流行情况、影像学表现及危险因素:系统评价和荟萃分析。
Eur Respir Rev. 2023 Mar 8;32(167). doi: 10.1183/16000617.0210-2022. Print 2023 Mar 31.
3
Trajectories and Prognostic Significance of 6-Minute Walk Test Parameters in Fibrotic Interstitial Lung Disease: A Multicenter Study.
纤维化间质性肺病 6 分钟步行试验参数的轨迹和预后意义:一项多中心研究。
Chest. 2023 Feb;163(2):345-357. doi: 10.1016/j.chest.2022.08.2233. Epub 2022 Sep 8.
4
The 6-min walk test as a primary end-point in interstitial lung disease.6 分钟步行试验作为间质性肺疾病的主要终点。
Eur Respir Rev. 2022 Aug 23;31(165). doi: 10.1183/16000617.0087-2022. Print 2022 Sep 30.
5
Interstitial lung diseases.间质性肺疾病
Lancet. 2022 Sep 3;400(10354):769-786. doi: 10.1016/S0140-6736(22)01052-2. Epub 2022 Aug 11.
6
Patient Characteristics and Survival for Progressive Pulmonary Fibrosis Using Different Definitions.使用不同定义的进行性肺纤维化患者的特征与生存情况
Am J Respir Crit Care Med. 2023 Jan 1;207(1):102-105. doi: 10.1164/rccm.202205-0910LE.
7
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.特发性肺纤维化(更新版)和成人进展性肺纤维化:美国胸科学会/欧洲呼吸学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2022 May 1;205(9):e18-e47. doi: 10.1164/rccm.202202-0399ST.
8
Derivation and validation of a simple multidimensional index incorporating exercise capacity parameters for survival prediction in idiopathic pulmonary fibrosis.一个简单的多维指数的推导和验证,纳入运动能力参数,用于特发性肺纤维化的生存预测。
Thorax. 2023 Apr;78(4):368-375. doi: 10.1136/thoraxjnl-2021-218440. Epub 2022 Mar 24.
9
Prediction of long-term mortality by using machine learning models in Chinese patients with connective tissue disease-associated interstitial lung disease.利用机器学习模型预测中国结缔组织病相关间质性肺病患者的长期死亡率。
Respir Res. 2022 Jan 7;23(1):4. doi: 10.1186/s12931-022-01925-x.
10
Bronchoalveolar lavage and lung biopsy in connective tissue diseases, to do or not to do?结缔组织病中的支气管肺泡灌洗和肺活检,做还是不做?
Ther Adv Musculoskelet Dis. 2021 Dec 8;13:1759720X211059605. doi: 10.1177/1759720X211059605. eCollection 2021.